Pergolide dosing compliance and factors affecting the laboratory control of equine pituitary pars intermedia dysfunction.

Background: Equine pituitary pars intermedia dysfunction (PPID) is treated with daily pergolide therapy. Owner compliance and its effect on PPID control have not been previously investigated.

Methods: Clinical records were searched to identify the sample of animals with PPID treated with pergolide from 2016 to 2019.